Lexicon Pharmaceuticals, Inc. LX31.MU Stock
Lexicon Pharmaceuticals, Inc. Price Chart
Lexicon Pharmaceuticals, Inc. LX31.MU Financial and Trading Overview
| Lexicon Pharmaceuticals, Inc. stock price | 3.53 EUR |
| Previous Close | 3.53 EUR |
| Open | 3.53 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 3.53 - 3.53 EUR |
| 52 Week Range | 3.53 - 3.53 EUR |
| Volume | 250 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 864.32M EUR |
| Beta (5Y Monthly) | 1.284859 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.55 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LX31.MU Valuation Measures
| Enterprise Value | 772.35M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6859.6865 |
| Price/Book (mrq) | 7.607759 |
| Enterprise Value/Revenue | 6129.772 |
| Enterprise Value/EBITDA | -7.145 |
Trading Information
Lexicon Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 1.284859 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.53 EUR |
| 52 Week Low | 3.53 EUR |
| 50-Day Moving Average | 3.53 EUR |
| 200-Day Moving Average | 3.53 EUR |
LX31.MU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 244.85M |
| Float | 82.65M |
| Short Ratio | N/A |
| % Held by Insiders | 1.16% |
| % Held by Institutions | 81.32% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -86128.57% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -45.38% |
| Return on Equity (ttm) | -122.16% |
Income Statement
| Revenue (ttm) | 126K EUR |
| Revenue Per Share (ttm) | 0.001 EUR |
| Quarterly Revenue Growth (yoy) | -35.099% |
| Gross Profit (ttm) | -52677000 EUR |
| EBITDA | -108092000 EUR |
| Net Income Avi to Common (ttm) | -110402000 EUR |
| Diluted EPS (ttm) | -0.55 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 105.94M EUR |
| Total Cash Per Share (mrq) | 0.56 EUR |
| Total Debt (mrq) | 55.59M EUR |
| Total Debt/Equity (mrq) | 63.14 EUR |
| Current Ratio (mrq) | 5.378 |
| Book Value Per Share (mrq) | 0.464 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -97043000 EUR |
| Levered Free Cash Flow (ttm) | -59122124 EUR |
Profile of Lexicon Pharmaceuticals, Inc.
| Country | Germany |
| State | TX |
| City | The Woodlands |
| Address | 2445 Technology Forest Boulevard |
| ZIP | 77381 |
| Phone | 281 863 3000 |
| Website | https://www.lexpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 135 |
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Q&A For Lexicon Pharmaceuticals, Inc. Stock
What is a current LX31.MU stock price?
Lexicon Pharmaceuticals, Inc. LX31.MU stock price today per share is 3.53 EUR.
How to purchase Lexicon Pharmaceuticals, Inc. stock?
You can buy LX31.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lexicon Pharmaceuticals, Inc.?
The stock symbol or ticker of Lexicon Pharmaceuticals, Inc. is LX31.MU.
Which industry does the Lexicon Pharmaceuticals, Inc. company belong to?
The Lexicon Pharmaceuticals, Inc. industry is Biotechnology.
How many shares does Lexicon Pharmaceuticals, Inc. have in circulation?
The max supply of Lexicon Pharmaceuticals, Inc. shares is 246.24M.
What is Lexicon Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Lexicon Pharmaceuticals, Inc. PE Ratio is now.
What was Lexicon Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Lexicon Pharmaceuticals, Inc. EPS is -0.55 EUR over the trailing 12 months.
Which sector does the Lexicon Pharmaceuticals, Inc. company belong to?
The Lexicon Pharmaceuticals, Inc. sector is Healthcare.